|
Re: Predictions ......
|
2
|
Resverlogix Corp.
|
Nov 16, 2019 12:59AM
|
|
Re: Power play
|
4
|
Resverlogix Corp.
|
Oct 09, 2019 08:52PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
8
|
Resverlogix Corp.
|
Nov 20, 2022 08:29AM
|
|
Re: Potential market
|
4
|
Resverlogix Corp.
|
Nov 17, 2019 03:49AM
|
|
Re: Potential market
|
6
|
Resverlogix Corp.
|
Nov 17, 2019 02:41PM
|
|
Re: Potential market
|
5
|
Resverlogix Corp.
|
Nov 17, 2019 03:49PM
|
|
Re: Possibility?
|
3
|
Resverlogix Corp.
|
May 10, 2024 08:59AM
|
|
Re: Possibility?
|
2
|
Resverlogix Corp.
|
May 07, 2024 02:22PM
|
|
Re: Possibility?
|
3
|
Resverlogix Corp.
|
May 08, 2024 10:06AM
|
|
Re: Positives vs. negatives
|
8
|
Resverlogix Corp.
|
Nov 21, 2019 10:20AM
|
|
Re: Positive data on cognition already 'baked in'?
|
4
|
Resverlogix Corp.
|
Dec 03, 2019 12:07PM
|
|
Re: Pondering the biomarkers...
|
7
|
Resverlogix Corp.
|
Nov 22, 2019 10:21AM
|
|
Re: Pitchforks
|
2
|
Resverlogix Corp.
|
Dec 19, 2020 08:01AM
|
|
Re: Pfizer working with Zenith but not Resverlogix....Is 3 a crowd?
|
4
|
Resverlogix Corp.
|
Jun 29, 2019 07:37PM
|
|
Re: Pfizer working with Zenith but not Resverlogix....Is 3 a crowd?
|
6
|
Resverlogix Corp.
|
Jun 30, 2019 09:47AM
|
|
Re: Pfizer working with Zenith but not Resverlogix....Is 3 a crowd?
|
3
|
Resverlogix Corp.
|
Jul 01, 2019 07:18AM
|
|
Re: Pfizer sees strong demand for COVID pill as profits surge.
|
5
|
Resverlogix Corp.
|
May 04, 2022 08:54PM
|
|
Re: Pfizer seems like a good fit for a BP deal
|
5
|
Zenith Epigenetics
|
Jan 10, 2024 03:57PM
|
|
Re: Pfizer seems like a good fit for a BP deal
|
7
|
Zenith Epigenetics
|
Jan 09, 2024 05:48PM
|
|
Re: Pfizer lays out ambitious vision for cancer portfolio in bid to reinvigorate its business.
|
9
|
Zenith Epigenetics
|
Mar 02, 2024 10:12AM
|
